OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Eric Chevet is Research Director at the French National Institute for Health and Medical Research (Inserm). After a Ph.D. in Molecular Cell Biology from the University of Paris XI in 1996 during which he studied growth factor signalling, he moved to Montreal, Canada for a post-doctoral fellowship at McGill University under the supervision of John Bergeron to work on the links between signalling and protein quality control in the endoplasmic reticulum. After this, he established his own laboratory at McGill University in 2001 as an assistant professor, before going back to France in 2006. For the past 20 years he has been investigating the role of endoplasmic reticulum stress signalling and proteostasis control in cancer development. Early 2015, he moved to Rennes in the West part of France to head a Cancer Research Laboratory within the Comprehensive Cancer Centre Eugène Marquis (INSERM U1242). The main objective of this research centre is to characterize select stress signalling pathways (including ER stress, death receptors, DNA damage, metabolism, non-coding RNA) in various cancers and develop novel relevant therapeutics to impede cancer development. Eric joins Traffic as Co-Editor in 2021.
